Register for Live Online Broadcast of Miami Myeloma Crowd Round Table on January 22

Register for Live Online Broadcast of Miami Myeloma Crowd Round Table on January 22

January 22 @ 9:00am — 3:30pm EST

If you cannot attend live but want to watch the first-ever Myeloma Crowd Round Table in Miami, Florida on Saturday, January 22, 2022, register here.

Our topics will be Myeloma Precursor Disease: What’s New, Where Are We Heading, and How to Manage and Monoclonal Antibodies and CAR T: When and How?

Dr. C. Ola Landgren, who moved to Miami from Memorial Sloan Kettering Cancer Center in New York last year, will host five world-class experts on the topics above.

For those who cannot attend—around the nation, the world or because of pandemic-based caution—the program will be broadcast live over the internet.  

Session one (Precursor Conditions) will begin at 9:00 am Eastern (6 am Pacific, 7 am Mountain, 8 am Central, 10 am Atlantic, 14:00 GMT, 15:00 CET).

Session two (Monoclonal Antibodies/CAR T) will begin at 1 pm Eastern (10 am Pacific, 11 am Mountain, 12 pm Central, 2 pm Atlantic, 18:00 GMT, 19:00 CET).

Our faculty will be:

  • C. Ola Landgren, MD, PhD, (host) Sylvester Cancer Center, University of Miami, Miami, FL
  • Dickran Kazandjian, MD, Sylvester Cancer Center, University of Miami, Miami, FL
  • Elisabet Manasanch, MD, MD Anderson Cancer Center, Houston, TX
  • Gareth Morgan, MD, PhD, Perlmutter Cancer Center, New York University, New York, NY
  • Nina Shah, MD, University of California at San Francisco, San Francisco, CA
  • Eric Smith, MD, PhD, Dana-Farber Cancer Institute, Boston, MA

Learn from these top myeloma experts about the latest research and treatment to find out what you can do to stay one step ahead for your best outcomes.  Extensive time for audience questions is included in every Round Table.

Schedule & Agenda

January 22 @ 9:00am — 3:30pm EST

Speakers & Moderators

Jennifer Ahlstrom

Jenny A - Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical resear...

Read Bio

Gareth Morgan, MD, PhD

Gareth Morgan, MD, PhD, is Director of Multiple Myeloma Research at NYU Langone Perlmutter Cancer Center in New York, NY. He is an internationally recognized clinician-scientist i...

Read Bio

Greg Brozeit

Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the...

Read Bio

Nina Shah, MD

Dr. Nina Shah is a specialist in blood diseases who focuses on treating multiple myeloma, a type of cancer affecting certain cells in the bone marrow. Her areas of professional int...

Read Bio

C. Ola Landgren, MD, PhD

C. Ola Landgren, MD, PhD, is Professor of Medicine, Chief of the Myeloma Program, and Leader of the Experimental Program at the University of Miami Sylvester Cancer Center. Read m...

Read Bio

Elisabet Manasanch, MD

Dr. Manasanch specializes in the treatment of patients with multiple myeloma. Furthermore, she focuses on translational research of the precursor stages of myeloma and early diseas...

Read Bio

Eric Smith, MD, PhD

Eric Smith moved to Boston after spending the early part of his career in New York. He earned his MD and PhD (Genetics and Genomic Sciences) from the Mount Sinai School of Medicine...

Read Bio

Dickran Kazandjian, MD

Dr. Kazandjian’s clinical and translational research interests lie in the treatment of precursor plasma cell disorders including high risk smoldering multiple myeloma and the rol...

Read Bio

About Myeloma Crowd Round Tables (MCRTs)

About Myeloma Crowd Round Tables (MCRTs)

Myeloma Crowd Round Tables (MCRTs) are education programs for myeloma patients and caregivers on a variety of treatment and research issues.  Each MCRT features presentations from internationally-recognized myeloma experts who also take extensive Q&A sessions from audience members.

Register Today!

January 22 @ 9:00am — 3:30pm EST

Event Sponsors





Thanks to our Myeloma Crowd Community sponsors:

.                         .       .